The placebo effect is the improvement a person experiences because of the context of a treatment (their expectations, past experience with medicine, the clinical ritual and the relationship with the person treating them) rather than because of any active ingredient. A placebo itself is an inert treatment, such as a sugar pill, a saline injection or a sham procedure. The best evidence shows placebo effects are real but mostly limited to how people feel, especially pain and nausea, and that they do not change objective disease.
The subject sits at the centre of the mind-over-matter question. If expectation can ease pain, it is tempting to conclude belief can heal anything; if placebo effects are statistical noise, it is tempting to dismiss the mind entirely. Seventy years of research supports neither extreme. This guide goes deeper than the short placebo section in the epigenetics and Biology of Belief pillar, covering the history, the mechanisms, open-label placebos and the nocebo effect.
What is a placebo, and what is the placebo effect?
A placebo is a treatment with no pharmacologically active content, while the placebo effect is the change produced by everything surrounding it. The pill is inert; the experience of being examined, handed a remedy and told it should help is not.
Researchers also separate the placebo effect from the "placebo response" measured in a clinical trial. When patients in the placebo arm of a trial improve, several things are mixed together:
- Natural recovery. Many conditions, from colds to back pain, improve on their own.
- Regression to the mean. People tend to enroll in trials when symptoms are at their worst, so later measurements drift back towards average whatever is given.
- Reporting bias. Patients may report improvement out of politeness, hope or a wish to please the clinician.
- The genuine placebo effect. The part caused by expectation, conditioning and the treatment ritual.
Only the last item is the placebo effect proper, and the only way to isolate it is to compare a placebo group with a group that receives no treatment at all.
Where the idea of the "powerful placebo" came from
The modern idea of a powerful placebo traces to Henry K. Beecher, a Harvard anaesthesiologist, and his 1955 paper "The Powerful Placebo" in the Journal of the American Medical Association. Beecher pooled 15 studies covering 1,082 patients across a range of conditions, and reported that about 35 percent were satisfactorily relieved by placebo alone. The figure became one of the most quoted numbers in medicine.
The number did not survive scrutiny. In 1997 Gunver Kienle and Helmut Kiene re-examined Beecher's sources in the Journal of Clinical Epidemiology under the title "The powerful placebo effect: fact or fiction?" They argued that the improvements Beecher counted could be explained by spontaneous improvement, natural fluctuation of symptoms, regression to the mean, additional treatments, polite answers and even misquotation, and that the studies he cited offered no real evidence of a placebo effect at all. Without untreated comparison groups, Beecher could not separate placebo effects from the natural course of illness.
Is the placebo effect real?
Yes, but it is far smaller and narrower than the 35 percent legend suggests. The clearest test came from Asbjørn Hróbjartsson and Peter Gøtzsche of the Nordic Cochrane Centre, who asked a simple question: in trials that included both a placebo group and a no-treatment group, how much better did the placebo group do?
Their paper "Is the Placebo Powerless?" (New England Journal of Medicine, May 2001) analysed 114 such trials covering 40 clinical conditions. For binary outcomes, such as whether a patient was or was not improved, and for objective measurements, placebo had no significant effect. For continuous subjective outcomes, especially pain, there was a small benefit, and the effect shrank as trials got larger, which suggests that small, weaker studies inflated it.
Their 2010 Cochrane review, covering 234 trials across 60 conditions, concluded that placebo interventions have no important clinical effects in general but can influence patient-reported outcomes, most clearly pain and nausea, while noting that true effects on self-reports are hard to separate from biased reporting. The fair summary: placebo effects exist, are modest on average, vary widely, and live mainly in perception.
How the placebo effect works in the brain
The strongest mechanistic evidence comes from pain research, where expectation has been shown to engage the body's own pain-control chemistry. In 1978 Jon Levine, Newton Gordon and Howard Fields of the University of California, San Francisco studied patients recovering from wisdom-tooth extraction. Published in The Lancet as "The mechanism of placebo analgesia," the study found that naloxone, a drug that blocks opioid receptors, increased pain in people who had responded to a placebo, but not in those who had not. The conclusion was that placebo pain relief depends, at least in part, on the release of endorphins and other endogenous opioids.
Fabrizio Benedetti and colleagues at the University of Turin turned the question around: they gave a real drug either openly, with the patient told what was coming, or hidden, through an infusion the patient did not know about. In a 2004 review in The Lancet Neurology, Luana Colloca, Benedetti and co-authors summarised the results across pain, anxiety and Parkinson's disease: the same treatment worked less well when the patient did not know they were receiving it. The difference between open and hidden delivery is, in effect, the placebo component of a real drug. Expectation does not replace the medicine; it adds to it.
Conditioning, in which the body learns to associate a pill or ritual with relief, and the quality of the clinician relationship add further routes, which is why researchers increasingly speak of context effects.
Open-label placebos: can a placebo work if you know it is a placebo?
Surprisingly, in some small studies it appears to, at least for symptoms people report themselves. The landmark trial is "Placebos without deception," led by Ted Kaptchuk of Harvard Medical School and published in PLoS ONE on 22 December 2010.
Eighty people with irritable bowel syndrome were randomised either to no treatment or to pills openly described as "placebo pills made of an inert substance, like sugar pills," along with an explanation that such pills had produced improvement in clinical studies through mind-body processes. Both groups had the same quality of interaction with their providers. After three weeks, 59 percent of the open-placebo group reported adequate relief of their symptoms, compared with 35 percent of the no-treatment group, and global improvement scores were also higher.
The limits are important. The trial was small, lasted three weeks, relied on self-reports and could not blind patients to their group, and the authors called for further research. It shows that a persuasive ritual can change how symptoms feel, not that a sugar pill repairs anything. The mental side of this, how expectations and habitual thoughts shape experience, is explored in the guide on how to reprogram your subconscious mind.
What placebos cannot do
Placebos change how people feel far more reliably than they change what is happening in the body, and the clearest demonstration is a 2011 asthma study. Michael Wechsler, Ted Kaptchuk and colleagues published "Active albuterol or placebo, sham acupuncture, or no intervention in asthma" in the New England Journal of Medicine. Forty-six patients were randomised and 39 completed a crossover design in which each person received an albuterol inhaler, a placebo inhaler, sham acupuncture and no intervention across repeated visits.
The objective measure, forced expiratory volume in one second (FEV1), rose by about 20 percent with albuterol and by about 7 percent with each of the other three interventions, including no treatment at all. On that measure, the placebos did nothing beyond the natural course. Yet patients rated their improvement almost the same with albuterol (50 percent), the placebo inhaler (45 percent) and sham acupuncture (46 percent), compared with 21 percent when nothing was done.
Feeling better is not the same as an airway opening, and in an asthma attack that gap is dangerous. The same principle applies across medicine: there is no good evidence that placebos shrink tumours, clear infections or repair tissue.
The nocebo effect: when expectation causes harm
The nocebo effect is the mirror image of the placebo effect: expecting harm can produce real, unpleasant symptoms. The term comes from the Latin for "I shall harm," and Walter Kennedy introduced it in medical writing in 1961 in a short paper titled "The nocebo reaction." Patients warned about side effects often report them even when they are taking an inert pill.
A striking modern example is the SAMSON trial, reported in the New England Journal of Medicine in 2020 by Frances Wood, James Howard, Darrel Francis and colleagues at Imperial College London. The participants had all previously stopped statins because of side effects. Each received twelve monthly bottles: four containing atorvastatin, four containing placebo and four empty. Sixty people were randomised and 49 completed the year. Symptom scores were higher in both statin and placebo months than in tablet-free months, and about 90 percent of the symptom burden reported while taking statins was also present while taking placebo. Half of the original participants were back on statins six months after the trial.
SAMSON is evidence about expectation and side-effect reporting, not a verdict on any individual's symptoms; some side effects are real and serious. No one should stop a prescribed medicine without talking to their prescriber.
Mind over matter: what the evidence supports
The evidence supports a real but bounded version of mind over matter. Expectation, meaning and context measurably shape subjective experience, especially pain, nausea and fatigue, and they do so through identifiable brain pathways such as endogenous opioids. What the evidence does not show is that belief alone changes objective disease, from blood counts to tumour size to lung function.
That bounded version still has practical value:
- Rituals matter. Deliberate practices, from wind-down routines to breathwork, can change how stressed or calm a person feels.
- Sleep, movement and relationships shape perception. Habits covered in biohacking for beginners influence how intensely pain and fatigue are felt, and the site's piece on gratitude and the brain touches the same theme.
- Transparency protects. Tell clinicians about everything being taken, including supplements.
- Belief is not a replacement for care. Use expectation to support treatment, never to substitute for it.
Billy Carson's reading
Billy Carson has not released a dedicated talk on the placebo effect. His nearest themes are the mind-body ideas in his short "Your Cells Are Listening To Your Mind Every Day" and the "Epigenetic Memories" clip carried with the epigenetics guide. The question he keeps returning to is how far the mind can influence the body, and placebo research is the most rigorous place to test it.
On the evidence, the answer has two halves. The mind demonstrably shapes the body's experience: expectation releases natural pain-relieving chemistry, open-label rituals change how symptoms feel, and fear of side effects can produce them. But the same studies draw a firm line at objective disease. Read that way, Carson's question becomes an invitation to use attention, meaning and practice deliberately, alongside medicine rather than instead of it. Earlier writing on the site, such as the mind-body connection in understanding consciousness, develops the philosophical side of the same idea.
Watch, read and go deeper
For conversations on consciousness, perception and the body, stream the Awaken Zone show on 4BK TV. The epigenetics and Biology of Belief guide covers what gene-expression research says about belief, and the subconscious mind guide linked above looks at the practices with the best support. Every evidence-checked health guide on the site is collected in the biohacking topic hub.
Frequently asked questions
How strong is the placebo effect?
On average, modest. Hróbjartsson and Gøtzsche's Cochrane review of 234 trials found no important general clinical effects, with small but measurable effects on patient-reported outcomes such as pain and nausea. Effects vary widely between individuals and settings.
Do open-label placebos really work?
Small trials suggest they can improve self-reported symptoms even when people know the pill is inert. In Kaptchuk's 2010 IBS study, 59 percent of the open-placebo group reported adequate relief versus 35 percent with no treatment. The study was small and short, and larger trials are still needed.
What is the difference between placebo and nocebo?
A placebo effect is improvement driven by positive expectation and context; a nocebo effect is a worsening or new symptom driven by negative expectation. In the SAMSON statin trial, about 90 percent of the symptom burden reported on statins also appeared on placebo, showing how strongly expectation shapes side-effect reporting.
Can the placebo effect cure disease?
No. Placebo effects mainly influence subjective experience, such as pain, nausea and fatigue. In the 2011 asthma study, patients felt nearly as much better with a placebo inhaler as with albuterol, but only albuterol produced the larger improvement in lung function.
Sources and further reading
- Beecher, H. K., "The Powerful Placebo," Journal of the American Medical Association 159(17), 1955.
- Kienle, G. S. and Kiene, H., "The powerful placebo effect: fact or fiction?," Journal of Clinical Epidemiology 50(12), 1997.
- Hróbjartsson, A. and Gøtzsche, P. C., "Is the Placebo Powerless? An Analysis of Clinical Trials Comparing Placebo with No Treatment," New England Journal of Medicine 344(21), 2001; and "Placebo interventions for all clinical conditions," Cochrane Database of Systematic Reviews, 2010.
- Levine, J. D., Gordon, N. C. and Fields, H. L., "The mechanism of placebo analgesia," The Lancet, 1978.
- Colloca, L., Lopiano, L., Lanotte, M. and Benedetti, F., "Overt versus covert treatment for pain, anxiety, and Parkinson's disease," The Lancet Neurology, 2004.
- Kaptchuk, T. J. et al., "Placebos without deception: a randomized controlled trial in irritable bowel syndrome," PLoS ONE, 2010.
- Wechsler, M. E. et al., "Active albuterol or placebo, sham acupuncture, or no intervention in asthma," New England Journal of Medicine 365(2), 2011.
- Wood, F. A. et al., "N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects," New England Journal of Medicine 383(22), 2020.
This article is for general information and is not medical advice. Anyone with symptoms, or considering changes to a medicine or treatment plan, should talk with a qualified clinician first.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
